CAPTRUST Financial Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$70K Buy
2024
Q1
Sell
2023
Q4
$4.14M Buy
2023
Q3
$3.16M Buy
2022
Q2
Sell
2022
Q1
$1K Buy
2021
Q4
$0 Buy